| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/05/2001 | WO2001047887A1 β-AMINO ACID COMPOUNDS AS INTEGRIN ANTAGONISTS |
| 07/05/2001 | WO2001047885A1 Substituted indole mannich bases |
| 07/05/2001 | WO2001047880A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047879A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | WO2001047878A1 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 07/05/2001 | WO2001047877A2 Process for the preparation of pure citalopram |
| 07/05/2001 | WO2001047874A1 (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| 07/05/2001 | WO2001047866A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | WO2001047859A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | WO2001047562A2 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 07/05/2001 | WO2001047558A1 Nerve protective drugs |
| 07/05/2001 | WO2001047543A2 Activation and inhibition of the immune system |
| 07/05/2001 | WO2001047539A1 Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract |
| 07/05/2001 | WO2001047533A2 INHIBITION OF GSK-3$g(b) |
| 07/05/2001 | WO2001047524A1 Method and composition for the treatment of pain |
| 07/05/2001 | WO2001047523A1 Method and composition for the treatment of pain |
| 07/05/2001 | WO2001047514A1 Use of hypoglycemic agent for treating impaired glucose metabolism |
| 07/05/2001 | WO2001047508A2 Combination of trimebutine with an opioid analgesic |
| 07/05/2001 | WO2001047506A2 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 07/05/2001 | WO2001047503A1 Transdermal administration of reboxetine |
| 07/05/2001 | WO2001047498A2 Hydrogel-driven layered drug dosage form comprising sertraline |
| 07/05/2001 | WO2001047497A2 Controlled release pharmaceutical composition containing tramadol hydrochloride |
| 07/05/2001 | WO2001012592A3 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 07/05/2001 | WO2001003720A9 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 07/05/2001 | WO2001002363A3 N-substituted glycine derivatives |
| 07/05/2001 | WO2001000824A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2000078332A3 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/05/2001 | WO2000078331A3 Il6ril6 chimera for the treatment of neurodegenerative diseases |
| 07/05/2001 | WO2000073278A3 5-phenyl-pyrimidine derivatives |
| 07/05/2001 | WO2000071679A3 Human oxidoreductase proteins |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000055137A8 Compounds and methods for modulation of estrogen receptors |
| 07/05/2001 | WO2000040247A8 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 07/05/2001 | WO2000018799A9 Artemin, a novel neurotrophic factor |
| 07/05/2001 | US20010007015 Can be used as the basic structures (template molecules) for inhibiting and analysing amyloid formation and cytotoxicity in amyloid illnesses |
| 07/05/2001 | US20010006971 Administering an antiallergen of loratadine or metabolite of loratadine, desloratadine; migraines, stroke, orthostatic hypotension, gastrointestinal stasis, nausea, dizziness and jet lag; also psychological disorders; 5-HT7 receptors |
| 07/05/2001 | US20010006967 Administering an analgesic amount of tramadol and an amount of an excitatory opioid receptor antagonist, e.g naltrexone, nalone, to lessen the antianalgesia, hyperalgesia, hyper-excitability, physical dependence and or tolerance |
| 07/05/2001 | US20010006966 Use of 1- (aminoalkyl) -3-quinoxaline-2-on derivatives for the preparation of compounds having an antioxidant action |
| 07/05/2001 | US20010006942 Inducing an immune response against a chemokine receptor molecule by administering an immunogenic chemokine receptor polypeptide from an extracellular region of a chemokine receptor molecule; treating inflammation, multiple sclerosis |
| 07/05/2001 | US20010006940 Human chorionic gonadotrophin (hCG) used to treat or prevent tumors, multiple sclerosis, inflammation or angiogenesis-dependent diseases |
| 07/05/2001 | US20010006686 Extract; antiinflammatory agent for treatment of cyclooxygenase-2 (COX-2) conditions such as arthritis, pain from cancer; selective inhibition of COX-2 over COX-1 |
| 07/05/2001 | DE19963178A1 Substituierte Indol-Mannichbasen Substituted indole Mannich bases |
| 07/05/2001 | DE19962924A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 07/05/2001 | CA2699568A1 Azaindoles |
| 07/05/2001 | CA2396693A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2396516A1 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 07/05/2001 | CA2396502A1 Substituted pyrrole mannich bases |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/05/2001 | CA2395996A1 Neuroprotective drug |
| 07/05/2001 | CA2395663A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395548A1 Imidazo 1,3,5 triazinones and the use thereof |
| 07/05/2001 | CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395454A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 07/05/2001 | CA2395418A1 Isoxazolo pyrimidinones and the use thereof |
| 07/05/2001 | CA2395410A1 Triazolotriazinones and the use thereof |
| 07/05/2001 | CA2395284A1 Inhibition of gsk-3.beta. |
| 07/05/2001 | CA2395275A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | CA2395242A1 Composition for inhibiting macrophage activity |
| 07/05/2001 | CA2395173A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | CA2394888A1 Compound and method for the treatment of pain |
| 07/05/2001 | CA2394880A1 Activation and inhibition of the immune system |
| 07/05/2001 | CA2394747A1 Use of trimebutine for treating pain |
| 07/05/2001 | CA2394745A1 Combination of trimebutine with an opioid analgesic |
| 07/05/2001 | CA2394727A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | CA2394561A1 Method and composition for the treatment of pain |
| 07/05/2001 | CA2394098A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | CA2393583A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | CA2392866A1 Substituted indole mannich bases |
| 07/04/2001 | EP1113015A1 Optically active 3-((2-piperazinyl-phenyl)methyl)-1-(4-(trifluoromethyl)-phenyl)-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists |
| 07/04/2001 | EP1112381A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 07/04/2001 | EP1112368A1 Use of protein kinase kiaa0551 as pharmaceutical |
| 07/04/2001 | EP1112363A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 07/04/2001 | EP1112362A2 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 07/04/2001 | EP1112272A1 Muscarinic agonists and antagonists |
| 07/04/2001 | EP1112266A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 07/04/2001 | EP1112262A1 SUBSTITUTED $g(g)-PHENYL-$g(D)-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO |
| 07/04/2001 | EP1112255A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 07/04/2001 | EP1112253A1 Branched alkyl pyrrolidine-3-carboxylic acids |
| 07/04/2001 | EP1112252A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 07/04/2001 | EP1112251A1 Azetidine derivatives, preparation and medicines containing them |
| 07/04/2001 | EP1112090A2 Method of stimulating prosaposin receptor activity |
| 07/04/2001 | EP1112089A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use |
| 07/04/2001 | EP1112082A2 Stable liquid formulations of botulinum toxin |
| 07/04/2001 | EP1112070A1 Novel substituted triazole compounds |
| 07/04/2001 | EP1112067A2 Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes |
| 07/04/2001 | EP1112065A1 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose deivative |
| 07/04/2001 | EP0850236B1 Piperazino derivatives as neurokinin antagonists |
| 07/04/2001 | EP0736038B1 Compounds with growth hormone releasing properties |
| 07/04/2001 | EP0618810B1 Bradykinin antagonist peptides |
| 07/04/2001 | EP0579615B1 New bi- and tricyclic aminoalcohol esters, their preparation and their use in medicaments |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1302208A Smilagenin and anzurogenin-D for curing Alzheimer's disease |
| 07/04/2001 | CN1302207A Combined therapy for bipolar disorders |
| 07/04/2001 | CN1301570A Use of nerve growth factor in curing organic solvent toxic peripheral neuropathy |
| 07/04/2001 | CN1301559A Method for producing medicine for curing epilepsy |
| 07/04/2001 | CN1301553A Capsule for calming the endopathic wind and eliminating febrile disease |
| 07/04/2001 | CN1301552A Method for producing medicine for curing vertigo |
| 07/04/2001 | CN1068001C Heterocycle substituted propenoid acid derivatives as NMDA antagonists |
| 07/04/2001 | CN1067998C Hydrate for medicinal use |